missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Noggin Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Marca: R&D Systems™ 6057-NG-01M/CF
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
Measured by its ability to inhibit BMP-4-induced alkaline phosphatase production by ATDC5 mouse chondrogenic cells. The ED50 for this effect is 0.0200-0.160 μg/mL in the presence of 50 ng/mL of Recombinant Human BMP-4 (Catalog # 314-BP ).
Especificaciones
Q13253 | |
Bioactivity | |
9241 | |
1 mg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
NOG, noggin, SYM1, symphalangism 1 (proximal), synostoses (multiple) syndrome 1, SYNS1, SYNS1A | |
Recombinant Protein | |
Human | |
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining. |
Bioactivity | |
Lyophilized from a 0.2μm filtered solution in PBS. | |
23kDa (monomer) | |
Mouse myeloma cell line,NS0-derived human Noggin protein Gln28-Cys232 | |
<0.10EU per 1μg of the protein by the LAL method. | |
NOG | |
Unconjugated | |
Reconstitute at 250μg/mL in PBS. |
Sugerencias de productos
Customers who viewed this item also viewed.
Viewing 1-4 of
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
R&D Systems™ Recombinant Human Noggin Protein > Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido